Sarepta Therapeutics Share Price Today
(NASDAQ: SRPT)

Name: Sarepta Therapeutics Share Price Today (NASDAQ: SRPT) - Sarepta Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sarepta Therapeutics share price is $62 & ₹5,250.63 as on 1 May 2025, 2.30 'hrs' IST

$62

▲

1.15

(1.89%)

Live

View live Sarepta Therapeutics share price in Dollar and Rupees. Guide to invest in Sarepta Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sarepta Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Sarepta Therapeutics share price movements

Today's Low: $59.82
Today's High: $62.00
$62.00
3.52%
Downside
Day's Volatility :3.52%
Upside
0.0%
52 Weeks Low: $48.01
52 Weeks High: $173.25
$62.00
22.56%
Downside
52 Weeks Volatility :72.29%
Upside
64.21%

Sarepta Therapeutics (SRPT) Returns

Period	Sarepta Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-47.28%	-5.5%	0.0%
6 Months	-52.36%	-6.0%	0.0%
1 Year	-51.94%	-0.8%	0.0%
3 Years	-17.5%	6.9%	-5.1%

Sarepta Therapeutics (SRPT) Key Statistics

in dollars & INR

Previous Close	$60.85
Open	$59.98
Today's High	$62.51
Today's Low	$59.82
Market Capitalization	$6.0B
Today's Volume	$2.1M
52 Week High	$173.25
52 Week Low	$48.01
Revenue TTM	$1.9B
EBITDA	$255.8M
Earnings Per Share (EPS)	$2.34
PE Ratio	26.29
Profit Margin	12.37%
Quarterly Earnings Growth YOY	2.45%
Return On Equity TTM	19.71%

How to invest in Sarepta Therapeutics Stock (SRPT) from India?

It is very easy for Indian residents to invest directly in Sarepta Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sarepta Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sarepta Therapeutics or SRPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sarepta Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sarepta Therapeutics shares which would translate to 0.014 fractional shares of Sarepta Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sarepta Therapeutics, in just a few clicks!

Returns in Sarepta Therapeutics (SRPT) for Indian investors in Rupees

The Sarepta Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sarepta Therapeutics investment value today

Current value as on today

₹50,436

Returns

₹49,564

(-49.56%)

Returns from Sarepta Therapeutics Stock

₹51,050 (-51.05%)

Dollar Returns

₹1,486 (+1.49%)

Indian investors sentiment towards Sarepta Therapeutics (SRPT)

-14.13%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Investment in Sarepta Therapeutics Shares from India has dropped by -14.13% over the past 30 days, indicating reduced transactional activity.

-57%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Sarepta Therapeutics Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sarepta Therapeutics

BlackRock Inc
11.53%
Vanguard Group Inc
9.36%
Capital Research & Mgmt Co - Division 3
8.96%
HHG PLC
4.46%
State Street Corp
4.19%
Farallon Capital Management, L.L.C.
2.95%

Analyst Recommendation on Sarepta Therapeutics

Rating

Trend

Buy

82%Buy

17%Hold

0%Sell

Based on 29 Wall street analysts offering stock ratings for Sarepta Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Sarepta Therapeutics Stock (SRPT)

What analysts predicted

Upside of 137.63%

Target:

$147.33

Current:

$62.00

Insights on Sarepta Therapeutics Stock (Ticker Symbol: SRPT)

Price Movement
In the last 3 months, SRPT stock has moved down by -46.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 362.93M → 658.41M (in $), with an average increase of 25.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 6.46M → 159.04M (in $), with an average increase of 79.8% per quarter
SRPT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 78.7% return, outperforming this stock by 130.6%
SRPT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 92.8% return, outperforming this stock by 108.6%
Price to Sales
ForSRPT every $1 of sales, investors are willing to pay $3.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Sarepta Therapeutics Technicals Summary

Sell

Neutral

Buy

Sarepta Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Sarepta Therapeutics (SRPT) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sarepta Therapeutics, Inc.	-4.62%	-52.36%	-51.94%	-17.5%	-46.29%
Biontech Se	14.33%	-8.63%	17.21%	-28.71%	130.79%
Regeneron Pharmaceuticals, Inc.	-10.3%	-38.35%	-36.12%	-12.75%	8.26%
Vertex Pharmaceuticals Incorporated	3.73%	5.86%	28.03%	91.98%	97.29%
Alnylam Pharmaceuticals, Inc.	-4.71%	-8.59%	78.75%	85.05%	99.51%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sarepta Therapeutics, Inc.	26.29	26.29	159.25	7.6	0.2	0.04	NA	15.77
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sarepta Therapeutics, Inc.	Buy	$6.0B	-46.29%	26.29	12.37%
Biontech Se	Buy	$29.5B	130.79%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	8.26%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$127.6B	97.29%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	99.51%	NA	-12.37%

About Sarepta Therapeutics

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Organization	Sarepta Therapeutics
Employees	1372
CEO	Mr. Douglas S. Ingram Esq.
Industry	Health Technology

Management People of Sarepta Therapeutics

Name	Title
Mr. Douglas S. Ingram Esq.	President, CEO & Director
Mr. Ian Michael Estepan	Executive VP & CFO
Mr. Bilal Arif	Executive VP & Chief Technical Operations Officer
Dr. Louise R. Rodino-Klapac Ph.D.	Executive VP, Chief Scientific Officer and Head of Research & Development
Mr. Dallan Murray	Executive VP & Chief Customer Officer
Ms. Francesca T. Nolan	Executive Director of Investor Relations and Corporate Communications
Ms. Cristin L. Rothfuss J.D.	Executive VP, Chief General Counsel & Corporate Secretary
Ms. Alison Nasisi	Executive VP & Chief People Officer
Dr. Diane L. Berry Ph.D.	Executive VP and Chief of Global Policy & Advocacy Officer
Mr. Joseph Bratica	Controller & VP

Important FAQs about investing in SRPT Stock from India :

What is Sarepta Therapeutics share price today?

Sarepta Therapeutics share price today stands at $62.00, Open: $61.37 ; Previous Close: $60.85 ; High: $62.00 ; Low: $59.82 ; 52 Week High: $173.25 ; 52 Week Low: $48.01.

The stock opens at $61.37, after a previous close of $60.85. The stock reached a daily high of $62.00 and a low of $59.82, with a 52-week high of $173.25 and a 52-week low of $48.01.

Can Indians buy Sarepta Therapeutics shares?

Yes, Indians can invest in the Sarepta Therapeutics (SRPT) from India.

With INDmoney, you can buy Sarepta Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sarepta Therapeutics at zero transaction cost.

How can I buy Sarepta Therapeutics shares from India?

It is very easy to buy Sarepta Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sarepta Therapeutics (SRPT) be purchased?

Yes, you can buy fractional shares of Sarepta Therapeutics with INDmoney app.

What are the documents required to start investing in Sarepta Therapeutics stocks?

To start investing in Sarepta Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.